WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006082518) PHARMACEUTICAL COMPOSITIONS WITH ENHANCED PERFORMANCE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/082518    International Application No.:    PCT/IB2006/000293
Publication Date: 10.08.2006 International Filing Date: 23.01.2006
Chapter 2 Demand Filed:    18.04.2006    
IPC:
C08B 13/00 (2006.01), A61K 9/16 (2006.01), A61K 9/14 (2006.01)
Applicants: PFIZER PRODUCTS INC. [US/US]; Eastern Point Road, Groton, CT 06340 (US) (For All Designated States Except US).
BABCOCK, Walter, Christian [US/US]; (US) (For US Only).
FRIESEN, Dwayne, Thomas [US/US]; (US) (For US Only).
LYON, David, Keith [US/US]; (US) (For US Only).
MILLER, Warren, Kenyon [US/US]; (US) (For US Only).
SMITHEY, Daniel, Tod [US/US]; (US) (For US Only)
Inventors: BABCOCK, Walter, Christian; (US).
FRIESEN, Dwayne, Thomas; (US).
LYON, David, Keith; (US).
MILLER, Warren, Kenyon; (US).
SMITHEY, Daniel, Tod; (US)
Agent: FULLER, Grover, F., Jr.; c/o Lawrence, Jackie, Pfizer Inc. MS8260-1615, Eastern Point Road, Groton, CT 06340 (US)
Priority Data:
60/649,993 03.02.2005 US
60/649,994 03.02.2005 US
Title (EN) PHARMACEUTICAL COMPOSITIONS WITH ENHANCED PERFORMANCE
(FR) COMPOSITIONS PHARMACEUTIQUES A EFFICACITE AMELIOREE
Abstract: front page image
(EN)Pharmaceutical compositions of a low-solubility drug and lower alkanoate-, phthalate- and trimellitate esters of hydroxypropyl methyl cellulose and lower alkanoate- and succinate esters of cellulose and methyl cellulose are disclosed that provide enhanced concentrations of the drug in a use environment.
(FR)La présente invention se rapporte à des compositions pharmaceutiques contenant un médicament à faible solubilité et des esters alcanoate, phtalate et trimellitate inférieurs d'hydroxypropylméthylcellulose et des esters alcanoate et succinate inférieurs de cellulose et de méthylcellulose, qui permettent d'augmenter les concentrations dudit médicament dans un environnement d'utilisation.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)